Report Describes Rare Co-Occurrence of JAK2, CALR & MPL Mutations
The patient was diagnosed with PMF and treated with a JAK2 inhibitor and COPD therapy. Because of nausea, physicians reduced the JAK2 inhibitor dose.
The patient was diagnosed with PMF and treated with a JAK2 inhibitor and COPD therapy. Because of nausea, physicians reduced the JAK2 inhibitor dose.
